Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 6, 2026 | $0.04 | −90.0% | $7.31B | +75.6% | $0.54 |
| Q1 FY26ended Mar 31, 2026 | Apr 23, 2026 | $0.20 | −47.4% | $3.98B | +9.4% | $0.36 |
| Q4 FY25ended Dec 31, 2025 | — | $0.26 | — | $4.50B | +10.5% | — |
| Q3 FY25ended Sep 30, 2025 | — | $0.49 | +8.9% | $4.31B | +10.7% | — |
| Q2 FY25ended Jun 30, 2025 | — | $0.40 | +5.3% | $4.16B | +6.1% | — |
| Q1 FY25ended Mar 31, 2025 | — | $0.38 | +15.2% | $3.64B | +4.8% | — |
| Q4 FY24ended Dec 31, 2024 | — | −$0.11 | −122.4% | $4.07B | +5.2% | — |
| Q3 FY24ended Sep 30, 2024 | — | $0.45 | +21.6% | $3.89B | +2.3% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Keurig Dr Pepper shares, not any token. As of Aug 6, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $0.38 | — | $3.92B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.33 | — | $3.47B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $0.49 | — | $3.87B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $0.37 | — | $3.81B | — | — |